| P50 | author | Luis de Lecea | Q59820744 |
| P2093 | author name string | Jana Schaich Borg | |
| | Matthew E Carter | |
| P2860 | cites work | Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q24315738 |
| | The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity | Q24317782 |
| | Role of lateral hypothalamic orexin neurons in reward processing and addiction | Q24658346 |
| | Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice | Q48510917 |
| | Structural properties of orexins for activation of their receptors. | Q48536757 |
| | Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity | Q48691942 |
| | Hypofunction of right temporoparietal cortex during emotional arousal in depression. | Q50792834 |
| | Hypocretin (orexin) deficiency in human narcolepsy. | Q55033530 |
| | A prospective study of psychophysiological arousal, acute stress disorder, and posttraumatic stress disorder | Q57772971 |
| | Sympathetic and cardiovascular actions of orexins in conscious rats | Q73279189 |
| | Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats | Q73536652 |
| | Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response | Q81152624 |
| | SB-334867-A: the first selective orexin-1 receptor antagonist | Q24674074 |
| | The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene | Q28142783 |
| | The concept of allostasis in biology and biomedicine | Q29029448 |
| | Neural substrates of awakening probed with optogenetic control of hypocretin neurons | Q29615343 |
| | Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation | Q29615680 |
| | Hypothalamic regulation of sleep and circadian rhythms | Q29619151 |
| | Neurons containing hypocretin (orexin) project to multiple neuronal systems | Q29619641 |
| | The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats | Q33892990 |
| | Excessive ethanol drinking following a history of dependence: animal model of allostasis | Q33900052 |
| | Reduced number of hypocretin neurons in human narcolepsy | Q33923479 |
| | Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior | Q34245006 |
| | Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake | Q34287174 |
| | The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness | Q34575514 |
| | Promotion of sleep by targeting the orexin system in rats, dogs and humans | Q34607196 |
| | Orexin neuronal circuitry: role in the regulation of sleep and wakefulness | Q34696872 |
| | Orexin receptor antagonists: medicinal chemistry and therapeutic potential | Q34803264 |
| | Genetic contributions to generalized arousal of brain and behavior | Q35978831 |
| | Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. | Q36356595 |
| | An essential role for orexins in emergence from general anesthesia | Q36446205 |
| | Afferents to the orexin neurons of the rat brain | Q36485245 |
| | The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions | Q36502696 |
| | Arousal and reward: a dichotomy in orexin function | Q36564127 |
| | Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins | Q36718073 |
| | The orexins/hypocretins and schizophrenia | Q36922767 |
| | Functions of orexins in peripheral tissues | Q37092319 |
| | Organization of brain somatomotor-sympathetic circuits. | Q37120255 |
| | Concepts and mechanisms of generalized central nervous system arousal | Q37203752 |
| | Orexin signaling mediates the antidepressant-like effect of calorie restriction | Q37269868 |
| | Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine | Q42015698 |
| | Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action | Q42512060 |
| | Attenuated defense response and low basal blood pressure in orexin knockout mice | Q44443166 |
| | Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus | Q44831631 |
| | Blood, sweat, and fears: the autonomic architecture of emotion. | Q45997568 |
| | Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. | Q46510757 |
| | A role for lateral hypothalamic orexin neurons in reward seeking | Q46650606 |
| | Cardiovascular regulatory actions of the hypocretins in brain | Q48159278 |
| | Hypocretin (orexin) loss in Parkinson's disease | Q48182911 |
| | A role for hypocretin (orexin) in male sexual behavior. | Q48241796 |
| | Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. | Q48475139 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 39-45 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | The brain hypocretins and their receptors: mediators of allostatic arousal | |
| P478 | volume | 9 | |